Danielle Cooke
Concepts (533)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriovenous Malformations | 27 | 2023 | 53 | 5.850 |
Why?
| | Embolization, Therapeutic | 30 | 2026 | 242 | 5.520 |
Why?
| | Intracranial Aneurysm | 21 | 2026 | 103 | 5.240 |
Why?
| | Endovascular Procedures | 24 | 2026 | 384 | 4.050 |
Why?
| | Central Nervous System Vascular Malformations | 14 | 2026 | 27 | 2.620 |
Why?
| | Cerebral Angiography | 25 | 2024 | 119 | 2.200 |
Why?
| | Subarachnoid Hemorrhage | 10 | 2022 | 71 | 2.190 |
Why?
| | Stents | 12 | 2026 | 556 | 2.110 |
Why?
| | Endothelial Cells | 8 | 2022 | 870 | 2.030 |
Why?
| | Biopsy | 7 | 2022 | 1077 | 1.920 |
Why?
| | Stroke | 19 | 2023 | 1258 | 1.850 |
Why?
| | Angiography, Digital Subtraction | 17 | 2025 | 48 | 1.780 |
Why?
| | Aneurysm, Ruptured | 7 | 2022 | 38 | 1.700 |
Why?
| | Arteriovenous Fistula | 8 | 2025 | 38 | 1.620 |
Why?
| | Robotics | 3 | 2024 | 87 | 1.380 |
Why?
| | Tomography, X-Ray Computed | 19 | 2025 | 2738 | 1.360 |
Why?
| | Intracranial Hemorrhages | 7 | 2022 | 100 | 1.100 |
Why?
| | Brain Ischemia | 10 | 2022 | 358 | 1.090 |
Why?
| | Basilar Artery | 2 | 2018 | 7 | 1.090 |
Why?
| | Retinoblastoma | 5 | 2023 | 42 | 1.040 |
Why?
| | Fluoroscopy | 8 | 2018 | 176 | 1.000 |
Why?
| | Retinal Neoplasms | 4 | 2018 | 37 | 1.000 |
Why?
| | Vasospasm, Intracranial | 6 | 2017 | 19 | 0.990 |
Why?
| | Automobile Driver Examination | 1 | 2026 | 9 | 0.960 |
Why?
| | Feasibility Studies | 6 | 2022 | 1095 | 0.920 |
Why?
| | Magnetic Resonance Imaging | 23 | 2025 | 3869 | 0.900 |
Why?
| | Humans | 154 | 2026 | 144957 | 0.890 |
Why?
| | Self-Management | 2 | 2025 | 201 | 0.880 |
Why?
| | Neurosurgery | 2 | 2022 | 41 | 0.860 |
Why?
| | Iliac Artery | 2 | 2014 | 55 | 0.830 |
Why?
| | Automobile Driving | 1 | 2026 | 157 | 0.810 |
Why?
| | Phantoms, Imaging | 6 | 2018 | 158 | 0.800 |
Why?
| | Risk Reduction Behavior | 1 | 2025 | 226 | 0.800 |
Why?
| | Magnetic Resonance Imaging, Interventional | 6 | 2016 | 29 | 0.780 |
Why?
| | Vascular Malformations | 5 | 2022 | 50 | 0.770 |
Why?
| | Radiography, Interventional | 5 | 2023 | 130 | 0.760 |
Why?
| | Educational Measurement | 1 | 2026 | 326 | 0.760 |
Why?
| | Robotic Surgical Procedures | 2 | 2025 | 182 | 0.760 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 965 | 0.750 |
Why?
| | Middle Aged | 66 | 2026 | 35928 | 0.750 |
Why?
| | Cerebral Hemorrhage | 7 | 2022 | 120 | 0.750 |
Why?
| | Stroke Rehabilitation | 1 | 2023 | 43 | 0.750 |
Why?
| | Retrospective Studies | 60 | 2026 | 17101 | 0.740 |
Why?
| | Thrombectomy | 8 | 2022 | 78 | 0.740 |
Why?
| | Aneurysm | 3 | 2021 | 37 | 0.740 |
Why?
| | Brain | 17 | 2025 | 2941 | 0.730 |
Why?
| | Male | 88 | 2026 | 72406 | 0.730 |
Why?
| | Radiosurgery | 8 | 2022 | 401 | 0.720 |
Why?
| | Software | 4 | 2020 | 692 | 0.720 |
Why?
| | Treatment Outcome | 35 | 2026 | 11695 | 0.670 |
Why?
| | Carotid Stenosis | 1 | 2022 | 102 | 0.660 |
Why?
| | Cerebral Arteries | 4 | 2017 | 58 | 0.660 |
Why?
| | Magnetic Resonance Angiography | 6 | 2020 | 251 | 0.650 |
Why?
| | Balloon Occlusion | 1 | 2020 | 39 | 0.630 |
Why?
| | Neuroimaging | 6 | 2025 | 292 | 0.630 |
Why?
| | Central Nervous System Diseases | 1 | 2021 | 74 | 0.620 |
Why?
| | Female | 86 | 2026 | 78376 | 0.620 |
Why?
| | Veins | 3 | 2022 | 68 | 0.620 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 31 | 0.620 |
Why?
| | Vascular Access Devices | 3 | 2018 | 30 | 0.610 |
Why?
| | Aged | 50 | 2026 | 25947 | 0.610 |
Why?
| | Cerebral Veins | 3 | 2021 | 16 | 0.610 |
Why?
| | Melphalan | 3 | 2018 | 43 | 0.580 |
Why?
| | Needles | 2 | 2018 | 62 | 0.570 |
Why?
| | Catheterization, Peripheral | 3 | 2016 | 119 | 0.570 |
Why?
| | Transcranial Magnetic Stimulation | 5 | 2020 | 64 | 0.560 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 19 | 0.560 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 42 | 0.550 |
Why?
| | Wounds, Stab | 1 | 2018 | 12 | 0.550 |
Why?
| | Jugular Veins | 1 | 2018 | 42 | 0.540 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 497 | 0.540 |
Why?
| | Neck Injuries | 1 | 2018 | 21 | 0.530 |
Why?
| | Aorta, Thoracic | 1 | 2020 | 286 | 0.510 |
Why?
| | Nerve Net | 5 | 2020 | 285 | 0.510 |
Why?
| | Lymphatic Abnormalities | 3 | 2022 | 20 | 0.500 |
Why?
| | Obsessive-Compulsive Disorder | 3 | 2023 | 58 | 0.500 |
Why?
| | Adult | 51 | 2026 | 40506 | 0.490 |
Why?
| | Angioplasty | 3 | 2022 | 50 | 0.460 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2015 | 10 | 0.450 |
Why?
| | Orbital Diseases | 2 | 2018 | 35 | 0.450 |
Why?
| | Disease Management | 3 | 2017 | 647 | 0.440 |
Why?
| | Tissue and Organ Harvesting | 1 | 2015 | 73 | 0.420 |
Why?
| | Renal Dialysis | 1 | 2018 | 462 | 0.420 |
Why?
| | Ventriculostomy | 3 | 2026 | 24 | 0.420 |
Why?
| | Magnetic Fields | 2 | 2014 | 24 | 0.410 |
Why?
| | Neural Pathways | 4 | 2020 | 311 | 0.410 |
Why?
| | Spinal Cord | 4 | 2025 | 382 | 0.410 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2020 | 285 | 0.400 |
Why?
| | Cell Separation | 1 | 2013 | 307 | 0.380 |
Why?
| | Pitch Perception | 2 | 2025 | 14 | 0.370 |
Why?
| | Cerebral Infarction | 3 | 2025 | 47 | 0.370 |
Why?
| | Mammary Arteries | 1 | 2012 | 8 | 0.370 |
Why?
| | Infusions, Intra-Arterial | 6 | 2018 | 61 | 0.370 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2013 | 42 | 0.360 |
Why?
| | Blood Vessel Prosthesis | 3 | 2019 | 140 | 0.360 |
Why?
| | Vertebral Artery Dissection | 1 | 2012 | 30 | 0.360 |
Why?
| | Clinical Protocols | 3 | 2018 | 282 | 0.360 |
Why?
| | Deep Brain Stimulation | 1 | 2015 | 213 | 0.360 |
Why?
| | Catheters | 4 | 2017 | 75 | 0.350 |
Why?
| | Brain Neoplasms | 2 | 2025 | 1322 | 0.350 |
Why?
| | Sclerotherapy | 4 | 2022 | 19 | 0.350 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 253 | 0.340 |
Why?
| | Radial Artery | 2 | 2021 | 70 | 0.340 |
Why?
| | Temporal Arteries | 1 | 2011 | 43 | 0.330 |
Why?
| | Cochlear Implants | 2 | 2025 | 95 | 0.330 |
Why?
| | Atherosclerosis | 1 | 2015 | 409 | 0.330 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2025 | 2584 | 0.330 |
Why?
| | Carotid Artery, Internal | 4 | 2019 | 45 | 0.330 |
Why?
| | Neuronavigation | 1 | 2010 | 8 | 0.320 |
Why?
| | Transcriptome | 3 | 2022 | 1046 | 0.310 |
Why?
| | Surgical Instruments | 1 | 2010 | 51 | 0.310 |
Why?
| | Ultrasonography, Doppler, Transcranial | 4 | 2017 | 48 | 0.310 |
Why?
| | Arteriovenous Malformations | 2 | 2020 | 29 | 0.300 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 311 | 0.300 |
Why?
| | Carotid-Cavernous Sinus Fistula | 2 | 2019 | 9 | 0.300 |
Why?
| | Cardiac Catheterization | 1 | 2013 | 560 | 0.290 |
Why?
| | Adolescent | 25 | 2026 | 22453 | 0.280 |
Why?
| | Brain Mapping | 5 | 2020 | 537 | 0.280 |
Why?
| | Aged, 80 and over | 13 | 2025 | 8279 | 0.280 |
Why?
| | Connectome | 5 | 2020 | 95 | 0.280 |
Why?
| | Magnetics | 4 | 2016 | 48 | 0.280 |
Why?
| | Vasodilator Agents | 1 | 2010 | 331 | 0.280 |
Why?
| | Ophthalmic Artery | 2 | 2018 | 7 | 0.270 |
Why?
| | Foramen Magnum | 2 | 2021 | 10 | 0.270 |
Why?
| | Cerebrovascular Circulation | 5 | 2022 | 280 | 0.270 |
Why?
| | Contrast Media | 4 | 2020 | 488 | 0.260 |
Why?
| | Cerebral Revascularization | 2 | 2020 | 22 | 0.260 |
Why?
| | United Kingdom | 2 | 2025 | 338 | 0.250 |
Why?
| | Motivation | 2 | 2022 | 610 | 0.250 |
Why?
| | Young Adult | 18 | 2025 | 14126 | 0.250 |
Why?
| | Licensure | 1 | 2026 | 16 | 0.240 |
Why?
| | Child | 26 | 2023 | 22657 | 0.240 |
Why?
| | Prospective Studies | 11 | 2025 | 7997 | 0.240 |
Why?
| | Speech Perception | 2 | 2025 | 91 | 0.240 |
Why?
| | Antineoplastic Agents, Alkylating | 2 | 2018 | 72 | 0.230 |
Why?
| | Risk Factors | 10 | 2023 | 10792 | 0.230 |
Why?
| | Washington | 1 | 2026 | 147 | 0.230 |
Why?
| | Sclerosing Solutions | 3 | 2022 | 10 | 0.230 |
Why?
| | Cohort Studies | 11 | 2023 | 5965 | 0.230 |
Why?
| | Healthy Lifestyle | 1 | 2025 | 37 | 0.230 |
Why?
| | Iatrogenic Disease | 1 | 2026 | 76 | 0.230 |
Why?
| | Embolectomy | 2 | 2017 | 13 | 0.220 |
Why?
| | Mutation | 6 | 2021 | 4099 | 0.220 |
Why?
| | Preoperative Care | 3 | 2021 | 380 | 0.220 |
Why?
| | Meningioma | 2 | 2016 | 87 | 0.220 |
Why?
| | Catheterization | 2 | 2017 | 183 | 0.220 |
Why?
| | Cervical Vertebrae | 2 | 2025 | 158 | 0.220 |
Why?
| | Drainage | 1 | 2026 | 185 | 0.220 |
Why?
| | Equipment Design | 6 | 2025 | 530 | 0.220 |
Why?
| | Time Factors | 4 | 2025 | 7183 | 0.220 |
Why?
| | Intracranial Arteriosclerosis | 2 | 2014 | 8 | 0.220 |
Why?
| | Infant | 13 | 2023 | 10039 | 0.210 |
Why?
| | Perfusion Imaging | 3 | 2022 | 65 | 0.210 |
Why?
| | Mosaicism | 2 | 2021 | 73 | 0.200 |
Why?
| | Radiography | 4 | 2014 | 845 | 0.200 |
Why?
| | Microsurgery | 2 | 2021 | 72 | 0.200 |
Why?
| | Transverse Sinuses | 1 | 2023 | 9 | 0.200 |
Why?
| | Imaging, Three-Dimensional | 3 | 2020 | 583 | 0.200 |
Why?
| | Evoked Potentials, Motor | 2 | 2020 | 50 | 0.200 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 3 | 2011 | 104 | 0.200 |
Why?
| | Computed Tomography Angiography | 3 | 2020 | 145 | 0.190 |
Why?
| | Swine | 6 | 2018 | 833 | 0.190 |
Why?
| | Implosive Therapy | 1 | 2023 | 47 | 0.190 |
Why?
| | Cerebral Cortex | 3 | 2022 | 465 | 0.190 |
Why?
| | Neurosurgical Procedures | 5 | 2022 | 202 | 0.180 |
Why?
| | Radiology, Interventional | 1 | 2023 | 49 | 0.180 |
Why?
| | Cochlear Implantation | 2 | 2025 | 82 | 0.180 |
Why?
| | Flow Cytometry | 2 | 2017 | 1173 | 0.180 |
Why?
| | Oxygen | 2 | 2025 | 995 | 0.180 |
Why?
| | Child, Preschool | 15 | 2021 | 11799 | 0.180 |
Why?
| | Giant Cell Arteritis | 1 | 2022 | 46 | 0.180 |
Why?
| | Polyarteritis Nodosa | 1 | 2021 | 11 | 0.170 |
Why?
| | Materials Testing | 2 | 2020 | 354 | 0.170 |
Why?
| | Hematoma | 1 | 2021 | 59 | 0.170 |
Why?
| | Machine Learning | 2 | 2024 | 587 | 0.170 |
Why?
| | Actins | 2 | 2013 | 425 | 0.170 |
Why?
| | Methamphetamine | 1 | 2022 | 71 | 0.170 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 94 | 0.170 |
Why?
| | Combined Modality Therapy | 3 | 2016 | 1268 | 0.170 |
Why?
| | Cerebrovascular Disorders | 1 | 2022 | 103 | 0.170 |
Why?
| | Gene Expression | 2 | 2017 | 1490 | 0.170 |
Why?
| | Program Evaluation | 1 | 2025 | 949 | 0.170 |
Why?
| | Iodine Compounds | 1 | 2020 | 4 | 0.170 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 31 | 0.170 |
Why?
| | Moyamoya Disease | 1 | 2020 | 20 | 0.170 |
Why?
| | Surgery, Computer-Assisted | 2 | 2019 | 84 | 0.170 |
Why?
| | Brain Infarction | 1 | 2020 | 23 | 0.160 |
Why?
| | Precision Medicine | 1 | 2025 | 458 | 0.160 |
Why?
| | Growth Disorders | 1 | 2021 | 86 | 0.160 |
Why?
| | Phenotype | 5 | 2021 | 3164 | 0.160 |
Why?
| | Blood Vessels | 1 | 2022 | 171 | 0.160 |
Why?
| | Orbit | 2 | 2011 | 64 | 0.160 |
Why?
| | Spinal Cord Diseases | 1 | 2020 | 41 | 0.160 |
Why?
| | Observer Variation | 2 | 2020 | 355 | 0.160 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 14 | 0.160 |
Why?
| | Nervous System Diseases | 2 | 2021 | 284 | 0.160 |
Why?
| | Models, Anatomic | 1 | 2020 | 84 | 0.160 |
Why?
| | Calcium Channel Blockers | 2 | 2022 | 165 | 0.160 |
Why?
| | Recurrence | 3 | 2020 | 1135 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1540 | 0.160 |
Why?
| | Head Injuries, Penetrating | 1 | 2020 | 6 | 0.160 |
Why?
| | Unconsciousness | 1 | 2020 | 22 | 0.160 |
Why?
| | Drug Administration Schedule | 1 | 2022 | 783 | 0.160 |
Why?
| | Equipment Failure Analysis | 2 | 2025 | 128 | 0.150 |
Why?
| | Pyrimidinones | 1 | 2020 | 126 | 0.150 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 96 | 0.150 |
Why?
| | Torticollis | 1 | 2019 | 17 | 0.150 |
Why?
| | Amnesia | 1 | 2019 | 47 | 0.150 |
Why?
| | Brain Stem | 1 | 2020 | 96 | 0.150 |
Why?
| | Polyvinyls | 2 | 2016 | 20 | 0.150 |
Why?
| | Mental Health | 2 | 2024 | 792 | 0.150 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3415 | 0.150 |
Why?
| | Behavioral Symptoms | 1 | 2019 | 43 | 0.150 |
Why?
| | Follow-Up Studies | 9 | 2021 | 5417 | 0.150 |
Why?
| | Dimethyl Sulfoxide | 2 | 2016 | 41 | 0.150 |
Why?
| | DCC Receptor | 1 | 2019 | 5 | 0.150 |
Why?
| | Blood Flow Velocity | 2 | 2017 | 413 | 0.150 |
Why?
| | Mental Health Services | 1 | 2024 | 474 | 0.150 |
Why?
| | Models, Neurological | 1 | 2021 | 254 | 0.150 |
Why?
| | Electrocardiography | 3 | 1998 | 663 | 0.140 |
Why?
| | Pyridones | 1 | 2020 | 199 | 0.140 |
Why?
| | Blood Pressure | 1 | 2025 | 1769 | 0.140 |
Why?
| | Aspirin | 1 | 2022 | 400 | 0.140 |
Why?
| | Rabbits | 2 | 2022 | 648 | 0.140 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 104 | 0.140 |
Why?
| | Family Health | 1 | 2019 | 191 | 0.140 |
Why?
| | Movement Disorders | 1 | 2019 | 70 | 0.140 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2019 | 557 | 0.140 |
Why?
| | Vascular Patency | 1 | 2018 | 121 | 0.140 |
Why?
| | Cell Count | 1 | 2019 | 321 | 0.140 |
Why?
| | Migraine Disorders | 1 | 2020 | 112 | 0.140 |
Why?
| | Plaque, Atherosclerotic | 1 | 2019 | 60 | 0.140 |
Why?
| | Retinal Vein | 1 | 2018 | 14 | 0.140 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 155 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2021 | 251 | 0.140 |
Why?
| | Heterozygote | 1 | 2019 | 315 | 0.130 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1495 | 0.130 |
Why?
| | Receptor, TIE-1 | 1 | 2017 | 1 | 0.130 |
Why?
| | Endoglin | 1 | 2017 | 19 | 0.130 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2017 | 56 | 0.130 |
Why?
| | Gyrus Cinguli | 1 | 2017 | 96 | 0.130 |
Why?
| | Phlebography | 1 | 2017 | 39 | 0.130 |
Why?
| | Prognosis | 9 | 2023 | 4293 | 0.130 |
Why?
| | Diagnostic Errors | 1 | 2018 | 175 | 0.130 |
Why?
| | von Willebrand Factor | 1 | 2017 | 85 | 0.130 |
Why?
| | Stress, Psychological | 1 | 2025 | 1153 | 0.130 |
Why?
| | Radiographic Image Enhancement | 1 | 2017 | 57 | 0.130 |
Why?
| | Memory | 1 | 2019 | 296 | 0.130 |
Why?
| | Retinal Diseases | 1 | 2018 | 101 | 0.120 |
Why?
| | Infant, Newborn | 8 | 2023 | 6434 | 0.120 |
Why?
| | Carotid Arteries | 1 | 2017 | 207 | 0.120 |
Why?
| | Microvessels | 1 | 2017 | 99 | 0.120 |
Why?
| | Workflow | 1 | 2017 | 185 | 0.120 |
Why?
| | Depression | 3 | 2022 | 1559 | 0.120 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2017 | 154 | 0.120 |
Why?
| | Depressive Disorder | 1 | 2019 | 387 | 0.120 |
Why?
| | Health Care Costs | 1 | 2019 | 427 | 0.120 |
Why?
| | Tantalum | 1 | 2015 | 3 | 0.120 |
Why?
| | Meningeal Arteries | 1 | 2015 | 3 | 0.120 |
Why?
| | Thalamus | 1 | 2017 | 126 | 0.120 |
Why?
| | Ferrous Compounds | 1 | 2015 | 26 | 0.120 |
Why?
| | Renal Artery | 1 | 2016 | 43 | 0.120 |
Why?
| | Magnets | 1 | 2015 | 21 | 0.120 |
Why?
| | Hematoma, Subdural, Intracranial | 1 | 2015 | 1 | 0.120 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 609 | 0.120 |
Why?
| | Quality Improvement | 1 | 2024 | 1291 | 0.110 |
Why?
| | Meningeal Neoplasms | 1 | 2016 | 94 | 0.110 |
Why?
| | American Heart Association | 1 | 2017 | 350 | 0.110 |
Why?
| | Aneurysm, False | 1 | 2015 | 45 | 0.110 |
Why?
| | Filtration | 1 | 2015 | 70 | 0.110 |
Why?
| | Ferric Compounds | 1 | 2015 | 55 | 0.110 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 2197 | 0.110 |
Why?
| | Genotype | 1 | 2020 | 1835 | 0.110 |
Why?
| | Time-to-Treatment | 1 | 2017 | 245 | 0.110 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1786 | 0.110 |
Why?
| | Blood Glucose | 1 | 2025 | 2330 | 0.110 |
Why?
| | Hearing Loss | 1 | 2019 | 247 | 0.110 |
Why?
| | Hemodynamics | 2 | 2017 | 1121 | 0.110 |
Why?
| | Telemedicine | 1 | 2024 | 948 | 0.110 |
Why?
| | Collateral Circulation | 1 | 2015 | 19 | 0.110 |
Why?
| | Laser Capture Microdissection | 1 | 2014 | 29 | 0.110 |
Why?
| | Biopsy, Needle | 1 | 2015 | 183 | 0.110 |
Why?
| | Intracranial Hypertension | 1 | 2015 | 41 | 0.110 |
Why?
| | Primary Health Care | 1 | 2025 | 1734 | 0.110 |
Why?
| | Drug Carriers | 1 | 2015 | 130 | 0.110 |
Why?
| | Lasers | 1 | 2015 | 132 | 0.110 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 149 | 0.110 |
Why?
| | Myocardial Infarction | 3 | 1998 | 1209 | 0.110 |
Why?
| | Vein of Galen Malformations | 1 | 2014 | 2 | 0.110 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 328 | 0.110 |
Why?
| | DNA, Complementary | 1 | 2014 | 277 | 0.110 |
Why?
| | Magnetic Phenomena | 1 | 2014 | 12 | 0.100 |
Why?
| | Biomarkers | 1 | 2025 | 4275 | 0.100 |
Why?
| | Decision Making | 2 | 2021 | 980 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 970 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 341 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2925 | 0.100 |
Why?
| | Reference Values | 1 | 2015 | 798 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2013 | 49 | 0.100 |
Why?
| | Optical Imaging | 1 | 2014 | 64 | 0.100 |
Why?
| | Recovery of Function | 1 | 2018 | 710 | 0.100 |
Why?
| | Tungsten | 1 | 2013 | 30 | 0.100 |
Why?
| | Artifacts | 1 | 2014 | 139 | 0.100 |
Why?
| | Skin | 2 | 2017 | 758 | 0.100 |
Why?
| | Alloys | 1 | 2013 | 38 | 0.100 |
Why?
| | Intracranial Thrombosis | 1 | 2012 | 19 | 0.090 |
Why?
| | Neck | 2 | 2023 | 108 | 0.090 |
Why?
| | Ketones | 1 | 2013 | 53 | 0.090 |
Why?
| | Costs and Cost Analysis | 2 | 2026 | 220 | 0.090 |
Why?
| | Carboxypeptidases | 1 | 1992 | 12 | 0.090 |
Why?
| | Paresis | 1 | 2012 | 30 | 0.090 |
Why?
| | Comorbidity | 2 | 2014 | 1660 | 0.090 |
Why?
| | Radiation Dosage | 1 | 2014 | 193 | 0.090 |
Why?
| | Aorta, Abdominal | 1 | 2012 | 52 | 0.090 |
Why?
| | Animals | 9 | 2022 | 38109 | 0.090 |
Why?
| | Zygoma | 1 | 2011 | 7 | 0.090 |
Why?
| | Proteoglycans | 1 | 1992 | 110 | 0.090 |
Why?
| | Cranial Sinuses | 2 | 2021 | 16 | 0.090 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 2118 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2022 | 4155 | 0.090 |
Why?
| | Serine Endopeptidases | 1 | 1992 | 128 | 0.090 |
Why?
| | Peptide Hydrolases | 1 | 1992 | 105 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 627 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2019 | 2832 | 0.080 |
Why?
| | Mast Cells | 1 | 1992 | 146 | 0.080 |
Why?
| | Patient Admission | 1 | 2012 | 218 | 0.080 |
Why?
| | Health Personnel | 1 | 2017 | 748 | 0.080 |
Why?
| | Cell Survival | 1 | 2013 | 1098 | 0.080 |
Why?
| | Parents | 1 | 2019 | 1403 | 0.080 |
Why?
| | Cerebral Ventriculography | 1 | 2010 | 2 | 0.080 |
Why?
| | Angiography | 3 | 2018 | 208 | 0.080 |
Why?
| | Echoencephalography | 1 | 2010 | 4 | 0.080 |
Why?
| | Hot Temperature | 1 | 2013 | 407 | 0.080 |
Why?
| | Organotechnetium Compounds | 1 | 2010 | 12 | 0.080 |
Why?
| | Cerebral Ventricles | 1 | 2010 | 54 | 0.080 |
Why?
| | Spinal Neoplasms | 1 | 2009 | 37 | 0.080 |
Why?
| | Anxiety Disorders | 2 | 2023 | 373 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2024 | 541 | 0.070 |
Why?
| | Datasets as Topic | 2 | 2020 | 122 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2022 | 452 | 0.070 |
Why?
| | Quality of Life | 1 | 2022 | 3192 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2609 | 0.070 |
Why?
| | Hydrocephalus | 1 | 2010 | 111 | 0.070 |
Why?
| | Functional Laterality | 2 | 2020 | 241 | 0.070 |
Why?
| | Emergency Medical Services | 1 | 1996 | 696 | 0.070 |
Why?
| | Sensitivity and Specificity | 4 | 2020 | 1990 | 0.070 |
Why?
| | Cysteine | 1 | 2010 | 210 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 781 | 0.070 |
Why?
| | Rupture | 2 | 2020 | 91 | 0.070 |
Why?
| | Arteries | 2 | 2022 | 259 | 0.070 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 655 | 0.070 |
Why?
| | Constriction, Pathologic | 2 | 2022 | 248 | 0.070 |
Why?
| | RNA | 1 | 2014 | 940 | 0.070 |
Why?
| | ROC Curve | 2 | 2022 | 615 | 0.070 |
Why?
| | Brain Injuries | 1 | 2013 | 508 | 0.070 |
Why?
| | Electromyography | 2 | 2020 | 415 | 0.060 |
Why?
| | Cerebellum | 2 | 2019 | 223 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3608 | 0.060 |
Why?
| | Longitudinal Studies | 3 | 2025 | 2947 | 0.060 |
Why?
| | Electronic Health Records | 2 | 2024 | 1177 | 0.060 |
Why?
| | Injections, Intra-Arterial | 2 | 2015 | 26 | 0.060 |
Why?
| | Registries | 1 | 2015 | 2385 | 0.060 |
Why?
| | Atlases as Topic | 1 | 2025 | 11 | 0.060 |
Why?
| | Reperfusion | 1 | 2025 | 54 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2015 | 4569 | 0.060 |
Why?
| | Anxiety | 2 | 2023 | 1110 | 0.050 |
Why?
| | Music | 1 | 2025 | 48 | 0.050 |
Why?
| | Regional Blood Flow | 2 | 2018 | 514 | 0.050 |
Why?
| | Patient Health Questionnaire | 1 | 2024 | 41 | 0.050 |
Why?
| | Age Distribution | 2 | 2014 | 403 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 6053 | 0.050 |
Why?
| | Camping | 1 | 2023 | 4 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3890 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1264 | 0.050 |
Why?
| | Phobic Disorders | 1 | 2023 | 35 | 0.050 |
Why?
| | Models, Animal | 2 | 2016 | 392 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2026 | 636 | 0.050 |
Why?
| | Physician's Role | 1 | 2024 | 220 | 0.050 |
Why?
| | Glasgow Coma Scale | 1 | 2023 | 213 | 0.050 |
Why?
| | Doxycycline | 1 | 2022 | 62 | 0.050 |
Why?
| | Pericytes | 1 | 2022 | 36 | 0.040 |
Why?
| | Technology | 1 | 2022 | 96 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5872 | 0.040 |
Why?
| | Psychiatry | 1 | 2024 | 195 | 0.040 |
Why?
| | Age Factors | 2 | 2021 | 3335 | 0.040 |
Why?
| | Head | 1 | 2022 | 120 | 0.040 |
Why?
| | Sodium | 1 | 2022 | 197 | 0.040 |
Why?
| | Skin Abnormalities | 1 | 2021 | 12 | 0.040 |
Why?
| | Mood Disorders | 1 | 2022 | 140 | 0.040 |
Why?
| | Aging, Premature | 1 | 2021 | 16 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2021 | 69 | 0.040 |
Why?
| | Psychosocial Support Systems | 1 | 2020 | 16 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 95 | 0.040 |
Why?
| | Expert Testimony | 1 | 2020 | 42 | 0.040 |
Why?
| | Intention | 1 | 2022 | 183 | 0.040 |
Why?
| | Models, Theoretical | 2 | 2014 | 582 | 0.040 |
Why?
| | Vietnam Conflict | 1 | 2020 | 5 | 0.040 |
Why?
| | Patient Advocacy | 1 | 2020 | 74 | 0.040 |
Why?
| | Survival Rate | 2 | 2014 | 2092 | 0.040 |
Why?
| | Headache | 1 | 2021 | 150 | 0.040 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2021 | 192 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 175 | 0.040 |
Why?
| | Coma | 1 | 2020 | 38 | 0.040 |
Why?
| | Canada | 1 | 2021 | 428 | 0.040 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 10 | 0.040 |
Why?
| | Defense Mechanisms | 1 | 2019 | 21 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 380 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 551 | 0.040 |
Why?
| | Corneal Edema | 1 | 1999 | 4 | 0.040 |
Why?
| | Neural Inhibition | 1 | 2020 | 178 | 0.040 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 1999 | 14 | 0.040 |
Why?
| | Endothelium, Corneal | 1 | 1999 | 19 | 0.040 |
Why?
| | Diplopia | 1 | 2019 | 27 | 0.040 |
Why?
| | Visual Cortex | 1 | 2020 | 84 | 0.040 |
Why?
| | Monocytes | 1 | 2022 | 538 | 0.040 |
Why?
| | Basal Ganglia | 1 | 2019 | 57 | 0.040 |
Why?
| | Gray Matter | 1 | 2020 | 92 | 0.040 |
Why?
| | Propensity Score | 1 | 2021 | 367 | 0.040 |
Why?
| | Refractive Errors | 1 | 1999 | 36 | 0.040 |
Why?
| | Pyramidal Tracts | 1 | 2019 | 30 | 0.040 |
Why?
| | Functional Neuroimaging | 1 | 2019 | 60 | 0.040 |
Why?
| | Cranial Nerve Diseases | 1 | 2019 | 43 | 0.040 |
Why?
| | Fibroblasts | 2 | 2022 | 1034 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 69 | 0.040 |
Why?
| | Corpus Callosum | 1 | 2019 | 72 | 0.040 |
Why?
| | Motor Cortex | 1 | 2019 | 65 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 359 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2020 | 521 | 0.030 |
Why?
| | Thiophenes | 1 | 1999 | 128 | 0.030 |
Why?
| | Symptom Assessment | 1 | 2019 | 137 | 0.030 |
Why?
| | Social Behavior | 1 | 2020 | 288 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1054 | 0.030 |
Why?
| | Polytetrafluoroethylene | 1 | 1998 | 25 | 0.030 |
Why?
| | Dermatologic Surgical Procedures | 1 | 1998 | 21 | 0.030 |
Why?
| | Paracentesis | 1 | 2018 | 16 | 0.030 |
Why?
| | Problem Behavior | 1 | 2019 | 102 | 0.030 |
Why?
| | Groin | 1 | 2017 | 13 | 0.030 |
Why?
| | Anterior Cerebral Artery | 1 | 2017 | 5 | 0.030 |
Why?
| | Coronary Care Units | 1 | 1998 | 26 | 0.030 |
Why?
| | Punctures | 1 | 2017 | 40 | 0.030 |
Why?
| | Coronary Disease | 1 | 2000 | 386 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2018 | 200 | 0.030 |
Why?
| | Middle Cerebral Artery | 1 | 2017 | 56 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 550 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2000 | 1311 | 0.030 |
Why?
| | Echocardiography | 1 | 2000 | 652 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 363 | 0.030 |
Why?
| | Carotid Artery, External | 1 | 2016 | 3 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2021 | 2920 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2000 | 541 | 0.030 |
Why?
| | Hemorrhage | 1 | 2022 | 809 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 381 | 0.030 |
Why?
| | Prostheses and Implants | 1 | 1998 | 141 | 0.030 |
Why?
| | Movement | 1 | 2019 | 294 | 0.030 |
Why?
| | Blood Volume | 1 | 2016 | 65 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2157 | 0.030 |
Why?
| | Parent-Child Relations | 1 | 2019 | 270 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 847 | 0.030 |
Why?
| | Smoking | 1 | 2023 | 1472 | 0.030 |
Why?
| | Genetic Variation | 1 | 2021 | 984 | 0.030 |
Why?
| | Gray Platelet Syndrome | 1 | 2015 | 4 | 0.030 |
Why?
| | Fibrous Dysplasia, Polyostotic | 1 | 2015 | 6 | 0.030 |
Why?
| | United States | 3 | 2021 | 15988 | 0.030 |
Why?
| | Venous Pressure | 1 | 2015 | 6 | 0.030 |
Why?
| | Dexamethasone | 1 | 2018 | 372 | 0.030 |
Why?
| | Image Enhancement | 1 | 2016 | 199 | 0.030 |
Why?
| | Confidence Intervals | 1 | 1996 | 333 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1172 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 421 | 0.030 |
Why?
| | Drug Compounding | 1 | 2015 | 107 | 0.030 |
Why?
| | Sex Distribution | 1 | 1996 | 386 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 122 | 0.030 |
Why?
| | Sulfonamides | 1 | 1999 | 581 | 0.030 |
Why?
| | Health Behavior | 1 | 2020 | 786 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 195 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2015 | 284 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1464 | 0.030 |
Why?
| | Particle Size | 1 | 2015 | 411 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2836 | 0.030 |
Why?
| | Mydriasis | 1 | 2013 | 10 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2015 | 129 | 0.030 |
Why?
| | Perfusion | 1 | 2015 | 250 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 435 | 0.030 |
Why?
| | Electromagnetic Radiation | 1 | 2013 | 3 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1054 | 0.020 |
Why?
| | Causality | 1 | 2014 | 126 | 0.020 |
Why?
| | Pandemics | 1 | 2022 | 1695 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2018 | 535 | 0.020 |
Why?
| | Benzophenones | 1 | 2013 | 16 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2014 | 334 | 0.020 |
Why?
| | Alzheimer Disease | 1 | 2019 | 622 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 304 | 0.020 |
Why?
| | Chymases | 1 | 1992 | 8 | 0.020 |
Why?
| | California | 1 | 2014 | 475 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2365 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1992 | 85 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2456 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 1992 | 131 | 0.020 |
Why?
| | Molecular Weight | 1 | 1992 | 327 | 0.020 |
Why?
| | Exocytosis | 1 | 1992 | 84 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2880 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1796 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1890 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7191 | 0.020 |
Why?
| | Polymers | 1 | 2013 | 499 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 112 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5233 | 0.020 |
Why?
| | Veterans | 1 | 2020 | 1603 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2852 | 0.020 |
Why?
| | Carcinoma, Renal Cell | 1 | 2009 | 234 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2883 | 0.020 |
Why?
| | Databases, Factual | 1 | 2012 | 1486 | 0.010 |
Why?
| | Kidney Neoplasms | 1 | 2009 | 412 | 0.010 |
Why?
| | Technetium Tc 99m Sestamibi | 1 | 2000 | 13 | 0.010 |
Why?
| | Radiopharmaceuticals | 1 | 2000 | 207 | 0.010 |
Why?
| | Keratoplasty, Penetrating | 1 | 1999 | 9 | 0.010 |
Why?
| | Administration, Topical | 1 | 1999 | 150 | 0.010 |
Why?
| | Ophthalmic Solutions | 1 | 1999 | 79 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1998 | 166 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1998 | 89 | 0.010 |
Why?
| | Regression Analysis | 1 | 2000 | 1003 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 115 | 0.010 |
Why?
| | Electrodes | 1 | 1998 | 115 | 0.010 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 1998 | 158 | 0.010 |
Why?
| | Surface Properties | 1 | 1998 | 410 | 0.010 |
Why?
| | Intraocular Pressure | 1 | 1999 | 328 | 0.010 |
Why?
| | Lymphocytes | 1 | 1998 | 382 | 0.010 |
Why?
| | Visual Acuity | 1 | 1999 | 489 | 0.010 |
Why?
| | Glaucoma | 1 | 1999 | 250 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 292 | 0.010 |
Why?
| | Surgical Wound Infection | 1 | 1998 | 316 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1998 | 760 | 0.010 |
Why?
| | Neutrophils | 1 | 1998 | 1134 | 0.010 |
Why?
|
|
Cooke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|